Preliminary Result of Phase 1 Trial of Orelabrutinib in Combination with Rituximab, Methotrexate, and Dexamethasone in Patients with Newly Diagnosed Primary CNS Lymphoma Implementing Bayesian Design for Dose-Seeking

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.6629-6630
Main Authors: Yuan, Yan, Wang, Qian, Zhuang, Dongxiao, Ding, Tianling, Chen, Hong, Zhu, Fengping, Zheng, Kang, Feng, Rui, Zheng, Jiajun, Zhang, Xiaoluo, Du, Zunguo, Zhu, Ping, Wu, Jinsong, Mao, Ying, Chen, Tong
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-159309